SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1873 2402
 

Sökning: L773:1873 2402 > (2000-2004) > Reactivity of serot...

Reactivity of serotonin in whole blood : relationship with drug response in obsessive-compulsive disorder

Humble, Mats, 1952- (författare)
Psychiatry of Northern Dalecarlia, Mora Hospital, Mora, Sweden; Karolinska Institutet, Division of Psychiatry, Danderyd Hospital, Danderyd, Sweden
Bejerot, Susanne, 1955- (författare)
Department of Neuroscience, Division of Psychiatry, Uppsala University, Uppsala, Sweden
Bergqvist, P. B. (författare)
Department of Clinical Pharmacology, Lund University, Lund, Sweden
visa fler...
Bengtsson, F. (författare)
Department of Clinical Pharmacology, Lund University, Lund Sweden; Department of Neuroscience and Locomotion, Division of Psychiatry, Linköping University Hospital, Linköping, Sweden
visa färre...
 (creator_code:org_t)
New York, USA : Elsevier, 2001
2001
Engelska.
Ingår i: Biological Psychiatry. - New York, USA : Elsevier. - 0006-3223 .- 1873-2402. ; 49:4, s. 360-368
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Obsessive-compulsive disorder responds almost only to potent serotonin reuptake inhibitors. Previous studies have suggested a relation between serotonergic function and clinical outcome in serotonin reuptake inhibitor treatment of obsessive-compulsive disorder.Methods: In a randomized, double-blind trial, comparing clomipramine, paroxetine, and a placebo in obsessive-compulsive disorder, serotonin levels in whole blood (WB-5-HT) were measured at baseline, after 1 week, and after 4 weeks of treatment and related to clinical outcome in 36 patients.Results: In patients treated with serotonin reuptake inhibitors there was a pronounced decrease of WB-5-HT, variable after 1 week and uniformly maximal after 4 weeks. The decrease of WB-5-HT after 1 week of serotonin reuptake inhibitor treatment correlated negatively with clinical outcome after 12 weeks (r = -.61, p =.0006); hence, patients with slower WB-5-HT reactivity eventually responded better to treatment. Baseline WB-5-HT, but not WB-5-HT reactivity, was related to season. Depression, autistic traits, and previous serotonin reuptake inhibitor treatment predicted nonresponse.Conclusions: A fast decrease of WB-5-HT was associated with poor clinical outcome. This may be related to faster serotonin efflux from platelets, which has previously been linked to autism. Further studies are necessary to identify the underlying mechanism and discern whether serotonin reuptake inhibitor-induced WB-5-HT decrease is clinically useful.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

Obsessive-compulsive disorder
serotonin
kinetics
serotonin reuptake inhibitors
autism
prediction of response
randomized controlled trial

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Humble, Mats, 19 ...
Bejerot, Susanne ...
Bergqvist, P. B.
Bengtsson, F.
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Psykiatri
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Klinisk medicin
och Neurologi
Artiklar i publikationen
Biological Psych ...
Av lärosätet
Örebro universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy